Clinical Evaluation of Matra Basti of Varun Taila and Prostogrit in Vatastheela (BPH)
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Assessment will be made on the basis of subjective and objective criteria
Study Overview
Brief Summary
In this trail , we are selecting the patients of vatastheela (BPH) in which we will do the intervention with Varun Taila Matra Basti procedure and Prostogrit tab
orally 2 tab BD (500 mg each) till the prostate size decrease . Assessment will be done on
the basis of subjective and objective parameters. Subjective parameters includes incomplete emptying, frequency, urgency,nocturia,weak flow , straining and objectives parameters include prostate size volume
Study Design
- Study Type
- Interventional
- Allocation
- Adaptive randomization, such as minimization
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 40.00 Year(s) to 80.00 Year(s) (—)
- Sex
- Male
Inclusion Criteria
- •Diagnosed cases of BPH along with lower urinary tract symptoms.
- •Grade 1 and 2 Prostate enlargement.
- •Controlled Hypertension and Diabetes Mellitus.
Exclusion Criteria
- •Serology positive
- •Stricture Urethra
- •Prostate carcinoma
- •Idiopathic bladder neck obstruction
- •Chronic Renal failure
- •Prostate calculi
- •Neurogenic bladder
- •K/C/O Cardiac disease.
Outcomes
Primary Outcomes
Assessment will be made on the basis of subjective and objective criteria
Time Frame: 0 , 13 week
Serum PSA (Prostate Specific Antigen) test.
Time Frame: 0 , 13 week
Urine Examination. (Routine/Microscopic)
Time Frame: 0 , 13 week
Ultra-Sonography (USG) of abdomen and pelvis (pre and post void)
Time Frame: 0 , 13 week
Secondary Outcomes
- Assessment will be made on the basis of subjective criteria(Incomplete emptying)